Document:

Non-Qualified Stock Option Grant Agreement for Non-Employee Directors

 EXHIBIT 10.99 
 NON-QUALIFIED 
 STOCK OPTION GRANT AGREEMENT 
 THIS AGREEMENT, made as of this ______ day of ______________, 200_ between Kindred Healthcare, Inc. (the “Company”) and ________________ (the
“Director”). 
 WHEREAS, the Company has adopted and maintains the Kindred Healthcare, Inc. 2001 Stock Option Plan for Non-Employee
Directors (Amended and Restated) (the “Plan”) to promote the interests of the Company and its subsidiaries and stockholders by allowing the Company to attract and retain highly qualified non-employee directors by permitting them to obtain
or increase their proprietary interest in the Company; 
 WHEREAS, the Plan provides for the grant to directors in the Plan of non-qualified
stock options to purchase shares of Common Stock of the Company. 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants
hereinafter set forth, the parties hereto hereby agree as follows: 
 1. Grant of Options. Pursuant to, and subject to, the terms and
conditions set forth herein and in the Plan, the Company hereby grants to the Director a non-qualified stock option (the “Option”) with respect to _______________ shares of Common Stock of the Company. 
 2. Grant Date. The Grant Date of the Option hereby granted is ____________ __, 200_. 
 3. Incorporation of Plan. All terms, conditions and restrictions of the Plan are incorporated herein and made part hereof as if stated herein. If
there is any conflict between the terms and conditions of the Plan and this Agreement, the terms and conditions of this Agreement, as interpreted by the Committee, shall govern. All capitalized terms used and not defined herein shall have the
meanings given to such terms in the Plan. 
 4. Exercise Price. The exercise price of each share underlying the Option hereby granted
is $                    . 
 5.
Vesting Date. The Option shall become exercisable as follows: Approximately one-fourth of the Option shall become exercisable on each of the first, second, third and fourth anniversaries of the Grant Date; provided that, the
number of shares to become exercisable on any Vesting Date shall be rounded up to the nearest share, but in no event shall more than the total number of shares underlying the Option 

  

 1 

 
become exercisable in the aggregate. Notwithstanding the foregoing, in the event of a Change in Control, the Option shall immediately become fully
exercisable. 
 6. Expiration Date. Subject to the provisions of the Plan and the terms of this Agreement, with respect to the Option
or any portion thereof which has not become exercisable, the Option shall expire on the date the Director ceases to be a director of the Company, and with respect to any Option or any portion thereof which has become exercisable, the Option shall
expire on the earlier of (i) the date of removal if the Director is removed for Cause; (ii) three months after the date the Director ceases to be a director of the Company for any reason other than for Cause or on account of death or
Disability; (iii) in the event of the Director’s death or Disability while a director of the Company, or in the case of the Director’s death within three months after the Director ceases to be a director (other than by reason of
removal for cause), 12 months after the date of the Director’s death or Disability, or (iv) the tenth anniversary of the Grant Date. 
 7. Exercise Procedure. Vested portions of the Option may be exercised, in whole or in part, by delivery to the Company’s principal office of a written notice of exercise, to the attention of the Corporate Secretary, no less than
three (3) business days in advance of the effective date of the proposed exercise (the “Exercise Date”), setting forth the number of shares of Common Stock with respect to which the Option is to be exercised, the Grant Date of the
Option and the Exercise Date and accompanied by full payment of the exercise price and all applicable withholding taxes. Applicable withholding taxes shall be calculated based on the excess of the Fair Market Value of the shares of Common Stock over
the exercise price as of the Exercise Date. 
 8. Construction of Agreement. Any provision of this Agreement (or portion thereof)
which is deemed invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction and subject to this section, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the
remaining provisions thereof in such jurisdiction or rendering that or any other provisions of this Agreement invalid, illegal, or unenforceable in any other jurisdiction. No waiver of any provision or violation of this Agreement by the Company
shall be implied by the Company’s forbearance or failure to take action. 
 9. Delays or Omissions. No delay or omission to
exercise any right, power or remedy accruing to any party hereto upon any breach or default of any party under this Agreement, shall impair any such right, power or remedy of such party nor shall it be construed to be a waiver of any such breach or
default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any
waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party or any provisions or conditions of this Agreement, shall be in writing and
shall be effective only to the extent specifically set forth in such writing. 
  

 2 

 10. Limitation on Transfer. The Option shall not be assignable or transferable other than by will
or by the laws of descent and distribution or in accordance with the Plan. 
 11. Integration. This Agreement, and the other documents
referred to herein or delivered pursuant hereto which form a part hereof contain the entire understanding of the parties with respect to its subject matter. There are no restrictions, agreements, promises, representations, warranties, covenants or
undertakings with respect to the subject matter hereof other than those expressly set forth herein and in the Plan. This Agreement, including without limitation the Plan, supersedes all prior agreements and understandings between the parties with
respect to its subject matter. 
 12. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which shall constitute one and the same instrument. 
 13. Governing Law. This Agreement shall be
governed by and construed and enforced in accordance with the laws of the State of Delaware without regard to the provisions governing conflict of laws. 
 14. Director Acknowledgment. The Director hereby acknowledges receipt of a copy of the Plan. The Director hereby acknowledges that all decisions, determinations and interpretations of the Committee in respect
of the Plan, this Agreement and the Option shall be final and conclusive. 
 IN WITNESS WHEREOF, the Company has caused this Agreement to be
duly executed by its duly authorized officer and said Director has hereunto signed this Agreement on his own behalf, thereby representing that he has carefully read and understands this Agreement and the Plan as of the day and year first written
above. 
  

			
	 KINDRED HEALTHCARE, INC.

	
	  
	 By:
	 	 Richard A. Lechleiter

	 Title:
	 	Executive Vice President and Chief Financial Officer
	
	  
	 Name of Individual

  

 3AMENDED 2005 BONUS PLAN

 Exhibit 10.15 
 STAKTEK AMENDED AND RESTATED 2005 BONUS INCENTIVE PLAN 
 Scope 
 Staktek established the Bonus Incentive Plan for 2005 (the “Bonus Plan”), a quarterly profit-sharing program, to reward employees for their contributions to the
Company. Profit sharing is based on two factors: (1) Company profitability and (2) attaining established goals. 
 Eligibility

 All employees employed at the Company’s Austin facility scheduled to work more than 30 hours per week are eligible to participate in the Bonus
Plan. Certain employees employed at the Company’s Reynosa, Mexico facility designated by the Chief Executive Officer are eligible to participate in the Bonus Plan. Profit sharing is calculated for all eligible employees as of the last day of
the quarter. No payment will be made to employees who have been terminated for cause or who have submitted their resignation prior to the payment date of any bonus payment. Temporary workers are not eligible to participate. 
 Funding 
 The Company will create a bonus pool when quarterly
earnings before interest, taxes, depreciation and amortization (“EBITDA”) is positive. The amount allocated to the bonus pool will be limited to 5% of EBITDA as calculated for the quarter, and will exclude the expense recorded for the
Bonus Program. For the third and fourth quarters of 2005 only, an additional amount will be added to the bonus pool. This additional amount will be 35% of “adjusted operating income.” Adjusted operating income is defined as pro forma
operating income (as reported by the Company), excluding the expense recorded for the Bonus Plan. 
 Payments 
 Bonuses will be paid within 40 days of the end of the quarter in which they are earned. For eligible employees employed for the full quarter for which payment will be
made, payments will be based on each employee’s annualized base salary, divided by four. The base salary will be calculated based on the base salary in effect on the last day of the applicable quarter. 
 For employees hired during a quarter, payment will be prorated based on the period of time they are employed during the applicable quarter. 
 For employees who take an approved leave of absence during a quarter (medical, disability, or other personal leave, except for leaving qualifying under the Family
Medical Leave Act) in excess of 15 working days per quarter (whether cumulative or intermittent, and whether full days or partial days, exceeding 120 hours in the aggregate), payment will be prorated based on the actual period of time they work
during the applicable quarter. 

 Method of Calculation: 
 Bonus payments will be calculated as a percentage of an employee’s base salary according to formulas based upon the employee’s category and performance in
achieving objective performance goals, as set forth below: 
  

							
	 Category
	  	 Base Bonus
	  	 Goals
	  	 Weighting

	 	  	 Multiplier
	  	 	  	 Factor

	 CEO
	  	1.20	  	EBITDA	  	100%
	 CTO (former CEO)
	  	1.20	  	EBITDA	  	100%
	 CFO
	  	0.70	  	Org. Specific & EBITDA	  	100%
	 General Counsel
	  	0.65	  	Org. Specific & EBITDA	  	100%
	 VP, Sales (1)
	  	0.65	  	Org. Specific & EBITDA	  	50% / 50%
	 GM, Enterprise Business
	  	0.65	  	Org. Specific & EBITDA	  	50% / 50%
	 VP, Operations
	  	0.65	  	Org. Specific & EBITDA	  	50% / 50%
	 VP, Sales (2)
	  	0.60	  	Org. Specific & EBITDA	  	50% / 50%
	 Distinguished Member (CTO Office)
	  	0.60	  	Org. Specific & EBITDA	  	50% / 50%
	 Senior Director
	  	0.45	  	Org. Specific & EBITDA	  	50% / 50%
	 Director
	  	0.35	  	Org. Specific & EBITDA	  	80% / 20%
	 Senior Member (CTO Office)
	  	0.35	  	Org. Specific & EBITDA	  	80% / 20%
	 Other Employees
	  	0.18	  	Org. Specific & EBITDA	  	100%

 Goal achievement can vary from 0% to 100%. EBITDA achievement is calculated as actual EBITDA performance for the
quarter divided by the EBITDA target for that quarter as established by the Board of Directors. 
 Deductions from
Payments: 
 Mandatory deductions, such as child support and garnishments, will be deducted from bonus payments. Federal tax will be withheld at the IRS
statutory rate then in effect, which may be different than the rate on regular earnings. 
 Goals 
 In most cases, employees will have multiple goals. In this case, the base bonus multiplier will be multiplied by the sum of the weighted scores for each goal in this
category. 
 Goals are not valid until reviewed and approved by the departmental Vice President and the Chief Executive Officer. The goal scoring methodology
is a required part of the goal setting process and must be documented and approved in order for a goal to be valid. Once established, the goal scoring method cannot be changed without written authorization of the Chief Executive Officer. 

Other 
 If the bonus pool is insufficiently funded to pay
all of the eligible bonuses, payments will be made on a pro-rata basis. There will be no carry-forward from quarter to quarter, and any funds not earned and/or paid in a quarter will be returned to the Company. EBITDA goals will be determined in
accordance with the annual financial plan review undertaken by the Board of Directors and management. 
 All decisions regarding the Bonus Plan will be made
by the Chief Executive Officer and will be final and binding on all participants. Neither the Bonus Plan nor any individual bonus payment will confer upon any employee any right with respect to his/her continuing employment relationship with the
Company, nor shall it interfere in any way with any employee’s right or the Company’s right to terminate employment at any time, with or without cause. 

	(1)	Direct report to the President 

  

	(2)	Direct report to the VP of Sales 

 The Board of Directors may amend, suspend or terminate the Bonus Plan at any time, provided that no amendment or
termination may materially and adversely impair an employee’s rights with respect to the Bonus Plan then in effect for the quarter in which changes are made. 
 No employee shall have any right to assign or otherwise transfer his or her rights, if any, under the Bonus Plan. Any purported assignment or transfer by an employee of his or her rights under the Bonus Plan shall be null and void and of no
force or effect.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}]]